SAN DIEGO, March 2, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025 )
Also on site :
- Mike Levin: 10 big steps to help us get back to common sense and common ground
- Mockly made a fake DM generator that’s actually user-friendly
- Beloved ‘Days of our Lives’ Star Breaks Silence After Emmy Snub